Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.1B | 17.1B | 17.5B | 16.0B |
Cost of revenue | 12.3B | 14.2B | 14.8B | 13.2B |
Gross profit | 4.7B | 2.9B | 2.7B | 2.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 796.5M | 672.1M | 636.7M | 620M |
Operating income | 3.7B | 2.0B | 1.9B | 2.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 524.9M | 514.3M | 300.1M | 313.4M |
Other income expense | — | — | — | — |
Pretax income | 3.8B | 2.0B | 2.0B | 2.1B |
Tax provision | 632.1M | 445.8M | 440M | 496.2M |
Net income | 3.2B | 1.6B | 1.5B | 1.6B |
Basic EPS | — | 3.5 | 3.6 | 3.8 |
Diluted EPS | — | 3.5 | 3.6 | 3.8 |
Basic average shares | — | 351.0M | 350.9M | 350.6M |
Diluted average shares | — | 351.0M | 350.9M | 350.6M |
EBITDA | 4.3B | 2.6B | 2.3B | 2.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | -361.4M | -352.7M | -260.6M | -265.7M |
Preferred stock dividends | 0 | 0 | 0 | 0 |